Gabapentin for the Treatment of Tinnitus

To assess the efficacy of Gabapentin.

  1. Tinnitus Talk
    The specific aim of the Gabapentin for the Relief of Idiopathic Subjective Tinnitus Trial is to assess the therapeutic benefit of Gabapentin (Neurontin®) for subjective idiopathic troublesome tinnitus. We employed a double-blind placebo-controlled randomized clinical trial design to assess the efficacy of Gabapentin. Adults, between the ages of 18 and 70 with idiopathic, subjective, troublesome, unilateral or bilateral, non-pulsatile tinnitus of 6 month's duration or greater and score of 38 or greater on the Tinnitus Handicap Inventory were enrolled.

    Estimated Enrollment: 160
    Study Start Date: April 2004
    Estimated Study Completion Date: February 2006